Author: BEF

by
CF Community, CF News, Research
March 20, 2019

Alcresta Therapeutics Receives 510(k) Clearance For Use of RELiZORB® in ChildrenRELiZORB, The Only Digestive Enzyme Cartridge for Patients Requiring Supplemental Enteral Nutrition, Now Cleared to Help Children Suffering from Fat MalabsorptionJuly 20, 2017 08:30 AM Eastern Daylight TimeWARREN, N.J.--(BUSINESS WIRE)--Alcresta Therapeutics, Inc., dedicated to developing...

by
Boomer Esiason Foundation, CF Community, CF News, Research, Therapies
March 20, 2019

SOURCE  Vertex Announces Positive Phase 1 & Phase 2 Data from Three Different Triple Combination Regimens in People with Cystic Fibrosis Who Have One F508del Mutation and One Minimal Function Mutation (F508del/Min)-Phase 2 data showed mean absolute improvements in ppFEV1 of 9.7 and 12.0 percentage points...

by
Boomer Esiason Foundation, CF News
March 20, 2019

The Boomer Esiason Foundation has awarded prestigious "Sacks for CF" academic scholarships to 30 outstanding students with cystic fibrosis.Through the NFL season, longtime BEF partner Abbvie makes a donation to the BEF Sacks for CF scholarship program for every quarterback sack recorded during NFL Monday...